OOIR: Observatory of International Research

Papers

(The median citation count of JAMA Dermatology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Error in Author Surname in Byline	195
Melanoma Screening	138
Can Serum Biomarkers for Prurigo Nodularis Expose Pathophysiology or Just Treatment Response?	134
Group Omitted From Article Byline	132
Frequency of Skin Biopsies for Psoriasis by Race and Ethnicity	106
Exanthematous Eruption in a Patient With Known Chronic Graft-vs-Host Disease and Recent Measles Vaccination	101
Assessment of Cutaneous Vasculitis and Quality of Life	88
Disordered Eating in Hidradenitis Suppurativa	82
Recurrence Rate of Melanoma In Situ Excised With a 5-mm Excisional Margin	82
Prevalence of Contact Allergens in Natural Skin Care Products From US Commercial Retailers	81
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice	76
Low-Dose Metformin and Profibrotic Signature in Central Centrifugal Cicatricial Alopecia	70
Tofacitinib for Treatment of Acquired Reactive Perforating Collagenosis	68
Asymptomatic Irregular Pigmented Lesions of the Vulva	68
Treatment With Ataluren for Wound Healing and Health Complications in a Patient With Junctional Epidermolysis Bullosa	67
Alopecia Areata	67
Safety and Efficacy of ICP-332 for Moderate to Severe Atopic Dermatitis	66
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records	63
Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults	62
Parental E-Cigarette Use and Pediatric Atopic Dermatitis	62
Skin Cancer Care in US Veterans—Serving Those Who Served	61
Outcomes Associated With Combination Shaving and Cryosurgery Treatment in Patients With Keloid Scars	61
Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer Prevention	58
Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab	58
SIGLEC-1 Expression in a Cohort of Patients With Lupus Erythematosus Treated With Anifrolumab	58

Preventing Hand-Foot Syndrome in Patients With Cancer	57
Prevalence and Patient Characteristics of Ectodermal Dysplasias in Denmark	56
JAMA Dermatology	55
Treatment With Topical Sirolimus for Recurrent Lymphatic Malformation of the External Urethral Meatus	55
Cutaneous Angiosarcoma	55
Perceptions of US-Based Muslim Patients of Their Dermatology Care	54
Biomarkers of Tretinoin Precursors and Tretinoin Efficacy in Patients With Moderate to Severe Facial Photodamage	54
Nicotinamide for Skin Cancer Chemoprevention	53
Association of Persistent Rubella Virus With Idiopathic Skin Granulomas in Clinically Immunocompetent Adults	53
Parvovirus B19 Infection	52
Pregabalin for Neuropathic Pain and Itch in Recessive Dystrophic Epidermolysis Bullosa	52
Human Papillomavirus Diversity in Asian Individuals With Cutaneous Squamous Cell Carcinoma	51
Adalimumab Monotherapy vs Adalimumab With Methotrexate for Psoriasis	50
Smoking Cessation and Risk of Hidradenitis Suppurativa Development	49
Subclinical Synovitis Among Patients With Psoriasis Without Musculoskeletal Involvement	48
Clinical and Pathological Spectrum of Prurigo Pigmentosa in Central European Individuals	48
Ultraprocessed Food Intake and Psoriasis	47
COVID-19 as a Risk Factor For Autoimmune Skin Disease	46
ALK-Positive Histiocytosis—A Distinct Histiocytic Entity Deserving Recognition—Reply	46
Current State of Dermatology Mobile Applications With Artificial Intelligence Features	46
JAMA Dermatology	45
Errors in Abstract, Results, and Table 1	44
Reexamining Medication Impact in Hidradenitis Suppurativa and Pregnancy—Reply	43
Cooling Research Fever in Dermatology—The Role of Community Service—Reply	42
Serum Immunoglobulin G Levels and Nicastrin Variation in Hidradenitis Suppurativa	42
Treatment of Severe Dermatitis, Multiple Allergies, and Metabolic Wasting With Dupilumab	42
The Quest for a More Accurate Diagnosis of Cellulitis	41
Methotrexate and Interstitial Lung Disease—Reply	41
Considerations Regarding Mohs Surgery for Early-Stage Merkel Cell Carcinoma	40
Supporting Dermatologic Health Services Research for Structurally Marginalized Patients	40
Errors in Figure 2	39
Sun Protection 101—Your Guide to Sunscreen	39
Rapid Improvement in Refractory Acute Generalized Exanthematous Pustulosis With Spesolimab	39
Spesolimab Response in a Patient With Steroid-Resistant Sweet Syndrome	39
Multiple Papules and Nodules on the Face and Extremities	38
Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma	38
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis—Coordinating Research Priorities to Move the Field Forward	38
Foscarnet-Induced Penile Ulceration	37
Antihypertensive Medications and Eczematous Dermatitis in Older Adults	35
Error in Figure 4	35
A Subcutaneous Nodule With a Central Punctum on the Thigh	34
Cardiovascular and Venous Thromboembolic Risk With JAK Inhibitors in Immune-Mediated Inflammatory Skin Diseases	34
Mohs Surgery vs Wide Local Excision in Primary High-Stage Cutaneous Squamous Cell Carcinoma	34
Federated Learning for Decentralized Artificial Intelligence in Melanoma Diagnostics	34
Validation of Case Identification for Melasma Using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision Codes	34
Alectinib In the Treatment of Systemic Juvenile Xanthogranuloma of Infancy With ALK Translocation	33
Clinical Characteristics Associated With Response to Biologics in the Treatment of Psoriasis	33
Trends in the Prevalence of Eczema Among US Children by Age, Sex, Race, and Ethnicity From 1997 to 2018	33
A Firm Pigmented Plaque on the Forearm of a Child	33
Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones	33

Error in Figure 1	32
JAMA Dermatology Peer Reviewers in 2022	32
Numerous Angiomatous Lesions in an Infant	32
Chloracne	32
Errors in Figure 2 and Table 2 Footnotes	32
Error in Table	31
Legislative Efforts Restricting Care for Transgender People	31
Error in Author Byline	31
A Tribute to Samuel Moschella	31
Value-Driven Skin Cancer Surveillance for Transplant Recipients	30
Development and Validation of a Scale to Assess Epidermolysis Bullosa Simplex Severity	28
Red Papulonodules in a Kidney Transplant Recipient	28
Incidence and Prevalence of Morphea	27
Use of Patient-Reported Outcomes in Acne Vulgaris and Rosacea Clinical Trials From 2011 to 2021	27
High-Dose Upadacitinib Therapy for Refractory Metastatic Crohn Disease	26
JAMA Dermatology	26
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus	26
Association of Different Prescribing Patterns for Oral Corticosteroids With Fracture Preventive Care Among Older Adults in the UK and Ontario	26
Research Fever in Dermatology—A Symptom of a Larger Problem	25
Safety and Efficacy of Topical Lovastatin Plus Cholesterol Cream vs Topical Lovastatin Cream Alone for the Treatment of Disseminated Superficial Actinic Porokeratosis	25
Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa	25
Clinical and Pathologic Factors in Stage I and II Melanoma Recurrence	25
Risk of New-Onset and Recurrent Depression and Anxiety Among Patients With Hidradenitis Suppurativa	24
Incidence of and Risk Factors for Keratinocyte Carcinoma After Pediatric Solid Organ Transplant	24
Hidradenitis Suppurativa and Smoking, Obesity, Psoriasis, Inflammatory Bowel Disease, and Systemic Sclerosis	24
International Eczema Council Definitions of Low Disease Activity and Remission in Atopic Dermatitis	24
Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea	24
Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body	23
Treatment of Actinic Keratosis via Destruction in Medicare Beneficiaries	23
Presentation, Diagnosis, and Treatment of Cutaneous Crohn Disease	23
Chemotherapy-Induced Pseudocellulitis Without Prior Radiation Exposure	23
Differences in Face-to-Face Time Spent With a Dermatologist Among Patients With Psoriasis Based on Race and Ethnicity	22
Incorporating Social Determinants of Health Into Medical Decision-making—Implications for Dermatology	22
Error in Table Footnote	22
Use of Reflectance Confocal Microscopy in Equivocal Lesions for the Diagnosis of Melanoma	22
Xeroradiography as a Noninvasive Tool in Diagnosing Calciphylaxis	21
Doxycycline Postexposure Prophylaxis (DoxyPEP) for Bacterial STI Prevention	21
Recurring Papules and Nodules on the Vulva	21
Errors in the Affiliations and Corresponding Author Sections	21
Global Psoriasis Burden and Forecasts to 2050	21
CLOVES Syndrome	21
Consent and Identifiability for Patient Images in Research, Education, and Image-Based Artificial Intelligence	21
Epidermolysis Bullosa Pruriginosa Treated With Upadacitinib	21
Botulinum Toxin for Refractory Digital Ischemia and Ulcers in Systemic Sclerosis	20
Symptoms of Cognitive Impairment Among Children With Atopic Dermatitis	20
JAK2 Fusions in Adult Patients With Mycosis Fungoides and CD30 Lymphoproliferative Disorders	20
Isotretinoin Treatment in Adolescence and Adult Height	20
Skin-Related Quality of Life During Autoimmune Bullous Disease Course	20
Outcomes Associated With Neutropenia and Lymphopenia in Epidermal Necrolysis	20
Recurrence Rate of Small Melanoma In Situ on Low-Risk Sites Excised With 5-mm Excisional Margin	20
Mendelian Randomization for Dermatology Research	20
Prevalence of Comorbidities Among Pediatric Patients With Hidradenitis Suppurativa	20
Association of Biologic Treatment in Hidradenitis Suppurativa With Reduced Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio	19
Successful Treatment of Stimulator of Interferon Genes–Associated Vasculopathy of Infantile Onset SAVI Syndrome With Anifrolumab	19
Cutaneous Herpetiform Ulcerations as the Presenting Sign of an Acute Aortic Occlusion	19
Potential Sexual Transmission of Tinea Pubogenitalis From TMVII	19
CLAPO Syndrome	19
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy	19
Palmar Fasciitis and Polyarthritis Syndrome	19
JAMA Dermatology	18
Smooth, Firm, Skin-Colored Papules on the Nasal Dorsum	18
Characterizing Chronic Cutaneous Immune-Related Adverse Events Following Immune Checkpoint Inhibitors	18
Projective Personification Approach to the Experience of People With Acne and Acne Scarring—Expressing the Unspoken	18
Fibromyalgia in Patients With Hidradenitis Suppurativa	18
Annular Erythematous Eruption in a Pediatric Patient	18
Evaluation of Gabapentin and Transforaminal Corticosteroid Injections for Brachioradial Pruritus	18
JAMA Dermatology Peer Reviewers in 2024	18
Safety and Efficacy of Anti–IL-23 Monoclonal Antibody QX004N for Patients With Psoriasis	18
Acrodermatitis Enteropathica	18
Eruptive Xanthomas	18
Sudden Conjunctivitis, Lymphopenia, and Rash Combined With Hemodynamic Changes (SCoRCH) After Trimethoprim-Sulfamethoxazole Use	17
Incidence Trends of Cutaneous Squamous Cell Carcinoma, Carcinoma In Situ, and Keratoacanthoma By Sex, Age, and Anatomical Site	17
Clinical and Serological Characterization of Orf-Induced Immunobullous Disease	17
Reframing and Corrections to Review of ICD Codes for Dermatologic Conditions	17
Solitary Verrucous Plaque on the Right Pretibial Region	17
Artificial Intelligence and Dermatology	17
HLA-B*58:01 and Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in the US	17
Assessment of Need for Improved Identification of a Culprit Drug in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis	17
Error in Text	17
The Importance of Hair in Black−White Race Relations	17

Benign Familial Pemphigus in Skin of Color	17
Errors in Byline and Figures 3 and 4	16
Epitope Spreading in Immune Checkpoint Inhibitor–Associated Bullous Pemphigoid	16
Targeting Cardiometabolic Disease to Improve Psoriasis—A New Treatment Paradigm Emerges	16
Geographic Distribution and Workforce Diversity of Dermatology Physician Assistants—Reply	16
Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata	16
Diversity and Career Goals of Graduating Allopathic Medical Students Pursuing Careers in Dermatology	16
Cobblestoning Monomorphic Papules of the Lower Extremities	16
Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank	16
Granulomatous Cheilitis in a Young Woman	16
Cost-Utility Analysis of Rituximab vs Mycophenolate Mofetil for the Treatment of Pemphigus Vulgaris	16
Keratinocyte Cancer Risk and Porokeratosis Mevalonate Pathway Variants	16
Diagnosis, Workup, and Treatment of Idiopathic Granulomatous Mastitis	16
Eruptive Acral Nevi Secondary to Treatment With Chemotherapy	16
Prevalence of Pretreatment Testing Recommended for Patients With Chronic Inflammatory Skin Diseases	15
Outpatient Dermatology Productivity Measures by Patient Race, Sex, and Age	15
Rubella Virus–Associated Granulomas in Immunocompetent Adults—Possible Implications	15
Generalized Atrophic Papules and Acute Abdominal Pain	15
JAMA Dermatology	15
A Reddish Semitransparent Tumor in an Adolescent Girl	15
Radiation Recall Dermatitis With Bruton Tyrosine Kinase Inhibitor Therapy	15
Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma	15
Pott Puffy Tumor	15
Improvement of Hailey-Hailey Disease With Topical Cinacalcet, 3%, Ointment	15
Outcomes of COVID-19 and Vaccination in Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab	15
Nonmelanoma Skin Cancer in Patients Older Than Age 85 Years Presenting for Mohs Surgery	15
Treatment of Netherton Syndrome With Abrocitinib	15
Granulomatosis With Polyangiitis Presenting With Strawberry Gums	15
Adjuvant Immunotherapy in Stage II Melanoma—Further Risk Stratification is Needed	14
Response of Severe Lupus Miliaris Disseminatus Faciei to Treatment With Ruxolitinib Cream	14
Delphi Panel for the Development of Diagnostic Criteria for Metastatic Cutaneous Crohn Disease	14
Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis	14
Genetic Susceptibility to Hidradenitis Suppurativa and Predisposition to Cardiometabolic Disease	14
Diagnosis of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors	14
Patient Perspectives on Living With Severe Prurigo Nodularis	14
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis	14
Safety and Effectiveness of Oral Nutraceuticals for Treating Acne	14
Incidence and Factors Associated With Second Primary Invasive Melanoma in Norway	13
JAMA Dermatology	13
Evidence-Based Clinical Practice Guidelines for Laser-Assisted Drug Delivery	13
Topical β-Blocker Wet Wrap Therapy for Amivantamab-Induced Scalp and Facial Necrosis	13
Response of Widespread Generalized Essential Telangiectasia Following Treatment With Oral Dabigatran	13
Tuberculous Mastitis	13
Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults	13
Hypertrophic Tongue Papillae in Cowden Syndrome/PTEN Hamartoma Tumor Syndrome	13
Annular Cutaneous Lesion of the Neck	13
Hereditary Leukonychia Associated With GJA1 Mutation	13
Genetic Variants Associated With Hidradenitis Suppurativa	13
JAMA Dermatology	13
Sunburn and Cutaneous Squamous Cell Carcinoma	13
Reanalysis Following Removal of Participants From 1 Site in Multicenter Trial of Upadacitinib vs Dupilumab for Atopic Dermatitis	13
Facilitators and Barriers to the Timely Diagnosis and Treatment of Melanoma in Latino Persons	13
Error in Box	13
Unusual Congenital Scalp Lesion in a Child	13
Cost-Effectiveness Analysis of 3D Total-Body Photography for People at High Risk of Melanoma	13
Intralesional Interleukin-2 Therapy for Treatment of Cutaneous Squamous Cell Carcinoma	13
Pigmentary Changes in a Woman With Oral Lichen Planus	13
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children	13
Risk of Hematologic Cancer in Patients With Undifferentiated Pruritus	12
Chronic Mucocutaneous Candidiasis Due to STAT1 Gene Variant	12
Clinical Features and Outcomes of Black Patients With Melanoma	12
Onychomycosis	12
Intralesional Certolizumab for Refractory Lupus Pernio	12
Sarcoidosis of the Skin	12
Reanalysis of Study After Removal of Participants in 1 Trial of Upadacitinib for Atopic Dermatitis	12
Mogamulizumab-Associated Kaposi Sarcoma in 2 Patients With Primary Cutaneous T-Cell Lymphomas	12
Treatment of Porokeratosis Ptychotropica With a Topical Combination of Cholesterol and Simvastatin	12
Gene-Environment Interaction Between CYP1B1 and Oral Contraception on Frontal Fibrosing Alopecia	12
Perspectives on Use of the Cutaneous Direct Immunofluorescence Assay—Reply	12
JAMA Dermatology	12
Genital and Perigenital “W”-Shaped Telangiectasias in Women With Limited Cutaneous Systemic Sclerosis	12
Olmsted Syndrome	12
Perspectives and Strategies to Minimize Harm From Melanoma Diagnosis	12
Treatment of Suspected Rubella Virus–Associated Granulomatous Dermatitis With Adalimumab	12
Cutaneous Adverse Events and Cancer Survival Prognosis With Immune Checkpoint Inhibitor Treatment	12
Relevance of Human Herpesvirus 6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms—Reply	12
JAMA Dermatology’s Commitment to Diversity, Equity, and Inclusion	12
Improving Outcomes in Chronic Graft-vs-Host Disease	12
Leprosy—Insufficient Evidence for Monthly Multidrug Therapy—Reply	11
Evaluation of Clinical Relevance and Biological Effects of Antirituximab Antibodies in Patients With Pemphigus	11
Clinical Associations of Degos-Like Lesions in Patients With Systemic Sclerosis	11
Navigating Melanoma In Situ in the Age of Overdiagnosis	11
Evaluation of the Validity of International Classification of Diseases Codes for Dermatologic Conditions	11
Long-Term Risk of Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19	11
Trichophyton mentagrophytes Internal Transcribed Spacer Genotype VIII	11
Prevention of Skin Cancers With Topical Calcipotriol and Fluorouracil in Patients With Xeroderma Pigmentosum	11
Multicentric Reticulohistiocytosis	11
Text Messaging for Cardiovascular Risk Prevention in Psoriasis	11
Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders	11
Factors Driving the Risk of Cognitive Impairment in Children With Atopic Dermatitis	11
Clinical Data on Laboratory Testing for Patients Taking Systemic Immunomodulatory Agents	11
Light-Related Cutaneous Symptoms of Erythropoietic Protoporphyria and Associations With Light Sensitivity Measurements	11
Antimicrobial Exposure and Immune-Related Cutaneous Adverse Events During Immune Checkpoint Blockade Therapy	11
Interleukin-17 Inhibitors and Early Major Adverse Cardiovascular Events	11
Bullous Pemphigoid Severity and Levels of Antibodies to BP180 and BP230	11